IVP Reports Strong Sales Growth Amid Challenges in Debtors Turnover Ratio
IVP, a microcap company in the commodity chemicals sector, reported its highest quarterly net sales in five quarters at Rs 149.36 crore for the quarter ending March 2025. Profit Before Tax rose to Rs 4.21 crore, while Profit After Tax increased to Rs 3.83 crore, despite a decline in the Debtors Turnover Ratio.
IVP, a microcap company in the commodity chemicals industry, has released its financial results for the quarter ending March 2025, declared on July 31, 2025. The evaluation changes indicate a notable shift in the company's score, which has moved to -2 from -12 over the past three months.The financial results reveal several positive aspects for IVP. The company achieved its highest quarterly net sales in the last five quarters, totaling Rs 149.36 crore, suggesting a favorable near-term sales trend. Additionally, the Profit Before Tax (PBT) reached Rs 4.21 crore, reflecting a growth of 29% compared to the average PBT of the previous four quarters, which stood at Rs 3.26 crore. Similarly, the Profit After Tax (PAT) was reported at Rs 3.83 crore, marking a 25.4% increase over the average PAT of Rs 3.06 crore from the prior four quarters, indicating a positive near-term trend in profitability.
However, the financial results also highlight a challenge for IVP, as the Debtors Turnover Ratio has reached its lowest point in the last five half-yearly periods at 2.96 times, indicating a slowdown in the company's pace of settling its debtors.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
